Brain+ ApS
Brain+ A/S, a healthtech company, develops and commercializes technology solutions in dementia care primarily for cognitive stimulation therapy. The company is developing Ayla, a scalable dementia care platform that offers practical, human-centered, and clinically proven software-based dementia therapy and care solutions. It is also developing Ayla " your CST Assistant, a software-based dementia … Read more
Brain+ ApS (BRAINP) - Net Assets
Latest net assets as of June 2025: Dkr14.45 Million DKK
Based on the latest financial reports, Brain+ ApS (BRAINP) has net assets worth Dkr14.45 Million DKK as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Dkr35.35 Million) and total liabilities (Dkr20.90 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Dkr14.45 Million |
| % of Total Assets | 40.87% |
| Annual Growth Rate | 6.05% |
| 5-Year Change | 472.6% |
| 10-Year Change | N/A |
| Growth Volatility | 312.44 |
Brain+ ApS - Net Assets Trend (2015–2024)
This chart illustrates how Brain+ ApS's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Brain+ ApS (2015–2024)
The table below shows the annual net assets of Brain+ ApS from 2015 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Dkr10.98 Million | -11.32% |
| 2023-12-31 | Dkr12.38 Million | -24.40% |
| 2022-12-31 | Dkr16.38 Million | -20.49% |
| 2021-12-31 | Dkr20.60 Million | +974.24% |
| 2020-12-31 | Dkr1.92 Million | -40.01% |
| 2019-12-31 | Dkr3.20 Million | -48.73% |
| 2018-12-31 | Dkr6.24 Million | -6.90% |
| 2017-12-31 | Dkr6.70 Million | +10.15% |
| 2016-12-31 | Dkr6.08 Million | -6.02% |
| 2015-12-31 | Dkr6.47 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Brain+ ApS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 589.4% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Dkr17.00 Million | 154.82% |
| Other Comprehensive Income | Dkr25.13 Million | 228.82% |
| Other Components | Dkr1.00 | 0.00% |
| Total Equity | Dkr10.98 Million | 100.00% |
Brain+ ApS Competitors by Market Cap
The table below lists competitors of Brain+ ApS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Cupani Metals Corp.
PINK:ICPLF
|
$969.50 |
|
Comptoir Group PLC
LSE:COM
|
$970.12 |
|
GCM RESOURCES
MU:LFD
|
$970.92 |
|
Rupali Polyester Ltd
KAR:RUPL
|
$971.11 |
|
Petrovietnam Gas City Investment and Development JSC
VN:PCG
|
$967.84 |
|
Husein Industries Limited
KAR:HUSI
|
$965.73 |
|
First Habib Modaraba
KAR:FHAM
|
$965.13 |
|
United Oil & Gas Plc
LSE:UOG
|
$964.66 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Brain+ ApS's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 12,384,756 to 10,982,449, a change of -1,402,307 (-11.3%).
- Net loss of 12,045,412 reduced equity.
- New share issuances of 12,545,849 increased equity.
- Other comprehensive income increased equity by 519,725.
- Other factors decreased equity by 2,422,469.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Dkr-12.05 Million | -109.68% |
| Share Issuances | Dkr12.55 Million | +114.24% |
| Other Comprehensive Income | Dkr519.73K | +4.73% |
| Other Changes | Dkr-2.42 Million | -22.06% |
| Total Change | Dkr- | -11.32% |
Book Value vs Market Value Analysis
This analysis compares Brain+ ApS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.10x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | Dkr6988.79 | Dkr0.01 | x |
| 2018-12-31 | Dkr6506.49 | Dkr0.01 | x |
| 2019-12-31 | Dkr0.18 | Dkr0.01 | x |
| 2020-12-31 | Dkr13.34 | Dkr0.01 | x |
| 2021-12-31 | Dkr2.58 | Dkr0.01 | x |
| 2022-12-31 | Dkr0.88 | Dkr0.01 | x |
| 2023-12-31 | Dkr0.32 | Dkr0.01 | x |
| 2024-12-31 | Dkr0.08 | Dkr0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Brain+ ApS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -109.68%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -153.28%
- • Asset Turnover: 0.24x
- • Equity Multiplier: 3.02x
- Recent ROE (-109.68%) is below the historical average (-50.10%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | -6.92% | -16.59% | 0.30x | 1.41x | Dkr-1.09 Million |
| 2016 | -6.41% | -19.75% | 0.18x | 1.83x | Dkr-997.81K |
| 2017 | -8.70% | -13.42% | 0.27x | 2.43x | Dkr-1.25 Million |
| 2018 | -7.41% | -7.68% | 0.26x | 3.65x | Dkr-1.09 Million |
| 2019 | -47.33% | -28.70% | 0.22x | 7.45x | Dkr-1.83 Million |
| 2020 | -66.68% | -21.28% | 0.20x | 15.58x | Dkr-1.47 Million |
| 2021 | -34.36% | -177.34% | 0.09x | 2.28x | Dkr-9.14 Million |
| 2022 | -59.08% | -366.22% | 0.06x | 2.77x | Dkr-11.32 Million |
| 2023 | -154.42% | -812.96% | 0.07x | 2.90x | Dkr-20.36 Million |
| 2024 | -109.68% | -153.28% | 0.24x | 3.02x | Dkr-13.14 Million |
Industry Comparison
This section compares Brain+ ApS's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $4,905,000
- Average return on equity (ROE) among peers: -68.52%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Brain+ ApS (BRAINP) | Dkr14.45 Million | -6.92% | 1.45x | $968.01 |
| Monsenso AS (MONSO) | $4.91 Million | -68.52% | 2.29x | $903.95K |